Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles

benzinga.com/trading-ideas/movers/25/10/48435389/intellia-freezes-key-trial-after-serious-liver-event-stock-tumbles

Intellia Therapeutics Inc. (NASDAQ:NTLA) shares tumbled after the company said it had temporarily paused patient dosing and screening in its Phase 3 MAGNITUDE and MAGNITUDE-2 trials of its experimental CRISPR therapy, nexiguran ziclumeran (nex-z), following a serious liver-related…

This story appeared on benzinga.com, 2025-10-27 14:38:29.
The Entire Business World on a Single Page. Free to Use →